Streetbeat News

Products Services

LTRN

Lantern Pharma is advancing its ADC program for solid tumor cancers, leveraging its RADR® AI platform and a unique conjugation approach. The cryptophycin-based ADC has shown high potency in preclinical tests and is aimed at tumors resistant to current therapies. Lantern plans to move towards IND development in 2024, targeting a market expected to generate over $24 billion by 2030.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 1:07 pm

UAVS

AgEagle Aerial Systems Inc. (NYSE:UAVS) has appointed William 'Bill' Irby as President, effective February 12, 2024. Irby brings over 25 years of senior management experience in the defense industry, particularly in unmanned technology. His appointment is expected to drive sustainable growth and expand AgEagle's market footprint, leveraging his expertise in scaling operations within the global defense and security industry.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 1:07 pm

ASC

Ardmore Shipping anticipates that in Q1 2024, all revenue days for its MR Tankers and Eco-Design IMO 2 Product/Chemical Tankers will be employed in the spot market.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 1:04 pm

NTLA

Intellia Therapeutics and ReCode Therapeutics have formed a strategic collaboration to develop genomic medicines for treating Cystic Fibrosis (CF), a serious genetic disease. While financial terms were not disclosed, Intellia is set to receive development and commercial milestone payments, along with royalties on potential sales. Intellia also has an option to lead commercialization in the U.S. for certain programs.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 12:34 pm

ITRG

Integra Resources has announced the second set of drill results from its 4,597 meter 2023 Highwall Geotechnical and Metallurgical Drill Program at the DeLamar Project in Southwestern Idaho. This update is part of the company's ongoing exploration and development efforts in the region.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 12:31 pm

CRDL

Cardiol Therapeutics announced that the FDA has granted Orphan Drug Designation to its lead drug candidate for the treatment of pericarditis. This designation is significant as it provides various benefits including tax credits, eligibility for market exclusivity, and assistance in the drug development process.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 12:30 pm

CLMB

Climb Channel Solutions, a subsidiary of Climb Global Solutions, Inc. (CLMB), has entered into a worldwide partnership with Panzura. This strategic alliance aims to enhance Climb's product offerings and expand its global reach.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 12:23 pm

DELL

NOK

Dell Technologies and Nokia have extended their strategic partnership, with Nokia adopting Dell as its preferred infrastructure partner for Nokia AirFrame customers. This agreement involves transitioning existing AirFrame customers to Dell's infrastructure portfolio for telecom cloud deployments.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 12:15 pm

META

Meta's decision to remove political content from Instagram and Threads recommendations has spotlighted Bluesky, a decentralized social media platform offering customizable feeds and user autonomy. Bluesky, backed by Jack Dorsey, has seen significant user growth, nearly doubling its base to 5 million. This contrasts with Meta's centralized control and recent moves to enhance election safeguards for 2024. Bluesky's integration with ActivityPub and its open approach to user content preferences position it as a strong competitor to Meta.

Portfolio Pulse from Benzinga Neuro

February 15, 2024 | 12:13 pm

SKYT

SkyWater Technology has entered into a production agreement with Nautilus Biotechnology, Inc. to manufacture silicon-based microfluidic bio chips for Nautilus' proteome analysis system. This partnership marks a significant step for both companies in the biotechnology and semiconductor sectors.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 12:11 pm